Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Lipella Pharmaceuticals Inc. (LIPO) Debt to Capital Ratio data is not available.
| Income Statement Financials | |
-- |
|
$-1.25M |
|
-- |
|
-- |
|
$1.27M |
|
$-1.27M |
|
$0.02M |
|
$-1.25M |
|
$-1.25M |
|
$-1.25M |
|
$-1.25M |
|
$-1.25M |
|
$-1.25M |
|
$-1.27M |
|
$-1.27M |
|
4.55M |
|
4.55M |
|
$-0.28 |
|
$-0.28 |
|
| Balance Sheet Financials | |
$2.08M |
|
$0.01M |
|
$0.27M |
|
$2.35M |
|
$0.64M |
|
-- |
|
$0.22M |
|
$0.86M |
|
$1.49M |
|
$1.49M |
|
$1.49M |
|
4.62M |
|
| Cash Flow Statement Financials | |
$-3.79M |
|
-- |
|
$3.46M |
|
$2.18M |
|
$1.86M |
|
$-0.33M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.24 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.79M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-84.30% |
|
-84.30% |
|
-53.37% |
|
-84.30% |
|
$0.32 |
|
$-0.83 |
|
$-0.83 |
|